October 6, 2023

Results from the in-vivo study on Surgify Safety Burr presented at the EANS2023 congress

We are happy to announce that last week, the results from the in-vivo study on Surgify Safety Burr from Helsinki University Hospital were presented at the #EANS2023 congress (European Association of Neurosurgical Societies) in Barcelona.

The study, by lead investigator Dr. Nuutti Vartiainen at the Department of Neurosurgery, Helsinki University Hospital, investigated the safety and efficacy of Surgify Safety Burr in an animal model.

The study concludes that Surgify Safety Burr is a safe and effective tool for common neurosurgical operations and offers clinically relevant benefits in this study setting. We thank the Department of Neurosurgery at Helsinki University Hospital for conducting the study.

If you wish to see the full poster – please get in touch with us.